MedPath

Improving treatment adherence in people with diabetes mellitus (INTENSE)

Conditions
Type 2 diabetes mellitus, medication non-adherence
Registration Number
NL-OMON21880
Lead Sponsor
Amsterdam UMC, location VUmc
Brief Summary

.A.

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
300
Inclusion Criteria

The main inclusion criteria are:

1)People with type 2 diabetes mellitus treated with oral blood glucose lowering drugs;
2)Non-adherent to oral blood glucose and/or blood pressure lowering drugs;
3)Aged 35-75 years;
4)Mobile phone user.

Exclusion Criteria

The main exclusion criteria are:

1)Use of insulin;
2)People that use medication-intake supporting services provided by the pharmacy;
3)People that suffer from major psychiatric disorders;
4)People that are ‘starters’, meaning that they started using the medicine somewhere in the period in which the dispensing score was calculated;
5)People that are ‘stoppers’, meaning that they did not have a medicine dispatch in the last four months of the period in which the dispensing score was calculated.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome measure of the study is medication adherence measured with a telephone pillcount. The pillcount will be conducted at baseline and after six months.
Secondary Outcome Measures
NameTimeMethod
The secondary outcome measures of the study are systolic blood pressure, HbA1c, self-reported medication adherence, attitude and beliefs toward medication, satisfaction with diabetes treatment, quality of life and medical and productivity costs. Blood pressure and HbA1c level will we obtained using registry data. Data on the other secondary outcome measures will be obtained using questionnaires.
© Copyright 2025. All Rights Reserved by MedPath